Dashboard
1
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 18.42% and Operating profit at 28.17% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 22.85% signifying low profitability per unit of shareholders funds
2
Flat results in Oct 25
3
With ROE of 24.82%, it has a very attractive valuation with a 2.97 Price to Book Value
4
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
JPY 53,818 Million (Small Cap)
12.00
NA
0.00%
0.56
20.91%
2.96
Revenue and Profits:
Net Sales:
5,218 Million
(Quarterly Results - Jan 2026)
Net Profit:
1,132 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
10.84%
0%
10.84%
6 Months
5.04%
0%
5.04%
1 Year
-8.99%
0%
-8.99%
2 Years
10.78%
0%
10.78%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Japan Eyewear Holdings Co. Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.42%
EBIT Growth (5y)
28.17%
EBIT to Interest (avg)
12.02
Debt to EBITDA (avg)
1.76
Net Debt to Equity (avg)
0.69
Sales to Capital Employed (avg)
0.54
Tax Ratio
19.79%
Dividend Payout Ratio
53.57%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
18.71%
ROE (avg)
22.85%
Valuation key factors
Factor
Value
P/E Ratio
12
Industry P/E
Price to Book Value
2.97
EV to EBIT
10.86
EV to EBITDA
8.20
EV to Capital Employed
2.18
EV to Sales
3.45
PEG Ratio
0.41
Dividend Yield
NA
ROCE (Latest)
20.07%
ROE (Latest)
24.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jan'26 - YoY
Jan'26
Jan'25
Change(%)
Net Sales
5,218.00
4,571.00
14.15%
Operating Profit (PBDIT) excl Other Income
2,150.00
1,851.00
16.15%
Interest
88.00
73.00
20.55%
Exceptional Items
-26.00
0.00
Consolidate Net Profit
1,132.00
1,571.00
-27.94%
Operating Profit Margin (Excl OI)
314.90%
307.60%
0.73%
USD in Million.
Net Sales
YoY Growth in quarter ended Jan 2026 is 14.15% vs 19.07% in Jan 2025
Consolidated Net Profit
YoY Growth in quarter ended Jan 2026 is -27.94% vs 92.52% in Jan 2025
Annual Results Snapshot (Consolidated) - Jan'26
Jan'26
Jan'25
Change(%)
Net Sales
18,640.00
16,666.00
11.84%
Operating Profit (PBDIT) excl Other Income
7,858.00
6,996.00
12.32%
Interest
338.00
421.00
-19.71%
Exceptional Items
-26.00
0.00
Consolidate Net Profit
3,783.00
3,994.00
-5.28%
Operating Profit Margin (Excl OI)
319.00%
319.30%
-0.03%
USD in Million.
Net Sales
YoY Growth in year ended Jan 2026 is 11.84% vs 23.20% in Jan 2025
Consolidated Net Profit
YoY Growth in year ended Jan 2026 is -5.28% vs 69.09% in Jan 2025
About Japan Eyewear Holdings Co. Ltd. 
Japan Eyewear Holdings Co. Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






